Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
Nipro Feb 2026
Carterra – 24th March 2025

Dissolution Specifications for Oral Drug Products (IR, DR, ER) in the USA – A Regulatory Perspective

The development of a dissolution method with suitable specifications is a key part of any oral drug product control strategy. Dissolution testing is a highly important in vitro technique for pharmaceutical dosage form in development
and formulation and, under certain specified conditions, the in vivo dissolution test can be replaced by an in vitro dissolution test. Balamuralidhara V et al. at JSS provide an overview of dissolution specifications and acceptance criteria that should be considered for IR, DR, ER dosage forms.

 

SAE Media – AI in DD
YPSOMED website ad
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
HCMed
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
Aptar – 08/01/2026
Nipro – 09.06.2025
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025